文献速递妇科生殖医学

超重和肥胖但体重正常的多囊卵巢综合征女性2型糖尿病风险增加:一项前瞻性人群出生队列研究

Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
PubMed 文献 · Hum Reprod · 2016-12-28

在1966年出生队列(n=5889)中,随访至46岁发现,超重/肥胖(BMI≥25.0 kg/m2)的多囊卵巢综合征(PCOS)女性2型糖尿病(T2DM)风险显著高于超重/肥胖对照(OR 2.45,95%CI 1.28-4.67),而体重正常的PCOS女性风险未增加。14至31岁体重增加在日后发展为T2DM的PCOS女性中更显著。

要点

  • 超重/肥胖PCOS女性T2DM风险较超重/肥胖对照升高(OR 2.45,95%CI 1.28-4.67)。
  • 体重正常PCOS女性糖尿病前期或T2DM风险未增加。
  • 14至31岁体重增加在发展为T2DM的PCOS女性中更显著(中位数27.25 kg vs 13.80 kg,P<0.001)。

核心结论

  • PCOS女性T2DM风险主要归因于超重和肥胖,两者对T2DM发生有协同效应。

研究设计与样本

  • 前瞻性、一般人群出生队列1966(n=5889),在14、31、46岁时邮寄问卷(应答率分别为95%、80%、72%)。
  • 31岁时3127名女性、46岁时3280名女性接受临床检查和血样采集;46岁时2780名女性行2小时口服葡萄糖耐量试验(OGTT)。
  • PCOS组(n=279)定义为31岁时报告稀发月经和多毛和/或46岁时诊断PCOS;对照组(n=1577)为31岁无症状且46岁无PCOS诊断。

主要发现

  • 超重/肥胖(BMI≥25.0 kg/m2)PCOS女性较超重/肥胖对照T2DM风险显著增加(OR 2.45,95%CI 1.28-4.67)。
  • 体重正常PCOS女性糖尿病前期或T2DM风险未增加。
  • 14至31岁体重增加在发展为T2DM的PCOS女性中大于糖耐量正常的PCOS女性(中位数27.25 kg vs 13.80 kg,P<0.001)。

关键数值与推荐

  • PCOS诊断基于自我报告,46岁问卷未区分仅超声卵巢多囊样改变与综合征。
  • 卵巢超声未用于辅助PCOS诊断。

临床怎么用

  • 作者认为结果强调从青春期和成年早期即应进行体重管理以预防PCOS女性T2DM。
  • 作者认为14至31岁似乎是 destined to develop T2DM by 46 years of age 的PCOS女性体重急剧增加的关键时间窗。
  • 作者认为结果支持在医疗资源有限时,OGTT筛查应针对超重/肥胖PCOS女性而非所有PCOS女性。

局限性

  • PCOS诊断基于自我报告。
  • 46岁问卷未区分仅超声卵巢多囊样改变与综合征。
  • 卵巢超声未用于辅助PCOS诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the respective roles of polycystic ovary syndrome (PCOS), long-term weight gain and obesity for the development of prediabetes or Type 2 diabetes mellitus (T2DM) by age 46 years? SUMMARY ANSWER: The risk of T2DM in women with PCOS is mainly due to overweight and obesity, although these two factors have a synergistic effect on the development of T2DM. WHAT IS KNOWN ALREADY: PCOS is associated with an increased risk of prediabetes and T2DM. However, the respective roles of PCOS per se and BMI for the development of T2DM have remained unclear. STUDY DESIGN, SIZE, DURATION: In a prospective, general population-based follow-up birth cohort 1966 (n = 5889), postal questionnaires were sent at ages 14 (95% answered), 31 (80% answered) and 46 years (72% answered). Questions about oligoamenorrhoea and hirsutism were asked at age 31 years, and a question about PCOS diagnosis at 46 years. Clinical examination and blood sampling were performed at 31 years in 3127 women, and at 46 years in 3280 women. A 2-h oral glucose tolerance test (OGTT) was performed at 46 years of age in 2780 women. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women reporting both oligoamenorrhoea and hirsutism at age 31 years and/or diagnosis of PCOS by 46 years were considered as women with PCOS (n = 279). Women without any symptoms at 31 years and without PCOS diagnosis by 46 years were considered as controls (n = 1577). The level of glucose metabolism was classified according to the results of the OGTT and previous information of glucose metabolism status from the national drug and hospital discharge registers. MAIN RESULTS AND THE ROLE OF CHANCE: PCOS per se significantly increased the risk of T2DM in overweight/obese (BMI ≥ 25.0 kg/m2) women with PCOS when compared to overweight/obese controls (odds ratio: 2.45, 95% CI: 1.28-4.67). Normal weight women with PCOS did not present with an increased risk of prediabetes or T2DM. The increase in weight between ages 14, 31 and 46 years was significantly greater in women with PCOS developing T2DM than in women with PCOS and normal glucose tolerance, with the most significant increase occurring in early adulthood (between 14 and 31 years: median with [25%; 75% quartiles]: 27.25 kg [20.43; 34.78] versus 13.80 kg [8.55; 20.20], P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The diagnosis of PCOS was based on self-reporting, and the questionnaire at 46 years did not distinguish between polycystic ovaries only in ultrasonography and the syndrome. Ovarian ultrasonography was not available to aid the diagnosis of PCOS. WIDER IMPLICATIONS OF THE FINDINGS: These results emphasize weight management already during adolescence and early adulthood to prevent the development of T2DM in women with PCOS, as the period between 14 and 31 years seems to be a crucial time-window during which the women with PCOS who are destined to develop T2DM by 46 years of age experience a dramatic weight gain. Furthermore, our results support the view that, particularly in times of limited sources of healthcare systems, OGTT screening should be targeted to overweight/obese women with PCOS rather than to all women with PCOS. STUDY FUNDING/COMPETING INTERESTS: Finnish Medical Foundation; North Ostrobothnia Regional Fund; Academy of Finland (project grants 104781, 120315, 129269, 1114194, 24300796, Center of Excellence in Complex Disease Genetics and SALVE); Sigrid Juselius Foundation; Biocenter Oulu; University Hospital Oulu and University of Oulu (75617); Medical Research Center Oulu; National Institute for Health Research (UK); National Heart, Lung, and Blood Institute (grant 5R01HL087679-02) through the STAMPEED program (1RL1MH083268-01); National Institute of Health/National Institute of Mental Health (5R01MH63706:02); ENGAGE project and grant agreement HEALTH-F4-2007-201413; EU FP7 EurHEALTHAgeing-277849 European Commission and Medical Research Council, UK (G0500539, G0600705, G1002319, PrevMetSyn/SALVE) and Medical Research Center, Centenary Early Career Award. The authors have no conflicts of interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ollila MM, West S, Keinänen-Kiukaanniemi S, et al. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod. 2016. PMID: 28031324. doi:10.1093/humrep/dew329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。